Multiple sclerosis (MS) is a disease affecting the central nervous system (CNS), affecting around 2.8 million people worldwide, including 130,000 in France. It is the leading cause of non-traumatic neurological disability in young adults. Hôpital Fondation Rothschild (HFAR) proposes to develop an AI algorithm enabling automated rereading of acquired susceptibility imaging as part of the diagnosis and follow-up of MS patients.

The Challenge aims to iinitiate an ambitious, long-term partnership between HFAR and a company that has demonstrated its ability to develop, validate and test an algorithm of interest for improving patient care. The competition will consist of:

• Detect the central vein sign in patients, and if a diagnosis of MS is not provided, give a probability of having this pathology.
• Detect the halo sign.